title: Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population.
abstract: Serum samples from 151 healthy individuals aged from 15 to 89 years were investigated by enzyme-linked immunosorbent assay (ELISA) for IgG levels against 11 different purified antigens from Staphylococcus aureus. Surface antigens, such as teichoic acid, clumping factors A and B, and bone sialoprotein binding protein, and extracellular proteins, such as alpha-toxin, lipase, enterotoxin A, toxic shock syndrome toxin, scalded-skin syndrome toxin, fibrinogen binding protein, and extracellular adherence protein, were used. The IgG values were analyzed in relation to the state of nasal carriage at the time of sampling. There was great individual variation in antibody levels in both young and elderly healthy subjects. Occurrence of S. aureus in the nares at the time of sampling was correlated with higher antibody levels, while elderly individuals over 65 years of age showed slightly lower levels than younger adults. More individuals than was expected from random probability calculations showed high antibody levels against several antigens, and more individuals than would be expected showed low levels against several antigens. Certain extracellular proteins had more often induced IgG levels of the same magnitude in the same individuals, indicating that among these individuals, there was a tendency to respond to certain antigens in the same way. Most individuals had circulating IgG antibodies to the 11 tested antigens, and some individuals had the tendency to be "good responders" to several antigens, while others were "poor responders." These findings constitute basic knowledge for the development of improved serological diagnostics, immune prophylaxis, individual prognosis tools, and therapy against invasive Staphylococcus aureus infections.
authors.affiliation: Department of Microbiology, Tumor and Cell Biology, Box 280, Karolinska Institutet, SE 171 77 Stockholm, Sweden. patricia.colque@ki.se
authors.forename: Patricia
authors.initials: P
authors.lastname: Colque-Navarro
authors.forename: Gunnar
authors.initials: G
authors.lastname: Jacobsson
authors.forename: Rune
authors.initials: R
authors.lastname: Andersson
authors.forename: Jan-Ingmar
authors.initials: JI
authors.lastname: Flock
authors.forename: Roland
authors.initials: R
authors.lastname: Möllby
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000907:Antibodies, Bacterial / Q000032:analysis*; D000937:Antigen-Antibody Reactions; D000942:Antigens, Bacterial / Q000276:immunology*; D000954:Antigens, Surface / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008875:Middle Aged; D013211:Staphylococcus aureus / Q000276:immunology*; D055815:Young Adult
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D000954:Antigens, Surface
references.citation: FEMS Microbiol Immunol. 1992 Jan;4(2):105-10
references.pmid: 1547022
references.citation: Clin Diagn Lab Immunol. 2005 Mar;12(3):387-98
references.pmid: 15753252
references.citation: Clin Diagn Lab Immunol. 2000 Jan;7(1):14-20
references.pmid: 10618270
references.citation: J Infect Dis. 2009 Mar 1;199(5):625-32
references.pmid: 19199541
references.citation: Eur J Clin Microbiol Infect Dis. 2010 Jun;29(6):715-25
references.pmid: 20383551
references.citation: Adv Microb Physiol. 2006;51:187-224
references.pmid: 17010697
references.citation: J Clin Microbiol. 1983 Apr;17(4):640-6
references.pmid: 6853691
references.citation: PLoS Med. 2008 Jan 15;5(1):e17
references.pmid: 18198942
references.citation: Biochem J. 2000 Feb 1;345 Pt 3:611-9
references.pmid: 10642520
references.citation: Lancet Infect Dis. 2005 Dec;5(12):751-62
references.pmid: 16310147
references.citation: J Infect Dis. 2006 Apr 15;193(8):1098-108
references.pmid: 16544250
references.citation: J Infect Dis. 1985 Aug;152(2):286-92
references.pmid: 4031544
references.citation: Eur J Clin Microbiol Infect Dis. 1991 May;10(5):447-9
references.pmid: 1874250
references.citation: J Med Microbiol. 1998 Mar;47(3):217-25
references.pmid: 9511827
references.citation: Infection. 1983 Mar-Apr;11(2):77-83
references.pmid: 6862637
references.citation: J Infect Dis. 2009 Jun 15;199(12):1820-6
references.pmid: 19419332
references.citation: J Infect Dis. 1991 Mar;163(3):530-3
references.pmid: 1995726
references.citation: Clin Vaccine Immunol. 2009 Jun;16(6):949-52
references.pmid: 19369478
references.citation: J Infect Dis. 2005 Feb 1;191(3):444-52
references.pmid: 15633104
references.citation: Infect Immun. 2008 Dec;76(12):5615-23
references.pmid: 18794290
references.citation: J Immunol Methods. 1995 Jun 28;183(2):279-90
references.pmid: 7602150
references.citation: Diagn Microbiol Infect Dis. 2002 Jan;42(1):9-15
references.pmid: 11821165
references.citation: Curr Opin Microbiol. 2007 Oct;10(5):428-35
references.pmid: 17921044
references.citation: Clin Microbiol Infect. 2001 Jun;7(6):301-7
references.pmid: 11442563
references.citation: N Engl J Med. 2001 Jan 4;344(1):11-6
references.pmid: 11136954
references.citation: J Infect. 2006 Nov;53(5):301-7
references.pmid: 16443276
references.citation: Nat Med. 2002 Jul;8(7):687-93
references.pmid: 12091905
references.citation: Arch Dis Child. 1987 Sep;62(9):905-11
references.pmid: 3118820
references.citation: J Med Microbiol. 1996 Mar;44(3):171-7
references.pmid: 8636933
references.citation: Clin Diagn Lab Immunol. 2001 Nov;8(6):1064-9
references.pmid: 11687441
references.citation: J Infect Dis. 2006 May 1;193(9):1275-8
references.pmid: 16586365